Works matching IS 17561841 AND DT 2020 AND VI 23 AND IP 2

Results: 21
    1

    APLAR Matters.

    Published in:
    International Journal of Rheumatic Diseases, 2020, v. 23, n. 2, p. 276, doi. 10.1111/1756-185X.13807
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9

    Singapore Chapter of Rheumatologists updated consensus statement on the eligibility for government subsidization of biologic and targeted‐synthetic therapy for the treatment of rheumatoid arthritis.

    Published in:
    International Journal of Rheumatic Diseases, 2020, v. 23, n. 2, p. 140, doi. 10.1111/1756-185X.13762
    By:
    • Leong, Joanna Wai Yee;
    • Cheung, Peter P.;
    • Dissanayake, Sajeewani;
    • Fong, Warren Weng Seng;
    • Leong, Keng Hong;
    • Leung, Ying Ying;
    • Lim, Anita Yee Nah;
    • Lui, Nai Lee;
    • Manghani, Mona;
    • Santosa, Amelia;
    • Sriranganathan, Melonie Kannamma;
    • Suresh, Ernest;
    • Tan, Teck Choon;
    • Teng, Gim Gee;
    • Lahiri, Manjari
    Publication type:
    Article
    10
    11

    Predictive factors for work‐day loss in Behçet's syndrome: A multi‐center study.

    Published in:
    International Journal of Rheumatic Diseases, 2020, v. 23, n. 2, p. 240, doi. 10.1111/1756-185X.13771
    By:
    • Mumcu, Gonca;
    • Yay, Meral;
    • Aksoy, Aysun;
    • Taş, Mehmet Nedim;
    • Armağan, Berkan;
    • Sarı, Alper;
    • Bozca, Burçin Cansu;
    • Tekgöz, Emre;
    • Karadağ, Duygu Temiz;
    • Badak, Suade Özlem;
    • Tecer, Duygu;
    • Bes, Cemal;
    • Şahin, Ali;
    • Erken, Eren;
    • Cefle, Ayse;
    • Çınar, Muhammet;
    • Yılmaz, Sedat;
    • Karaçaylı, Ümit;
    • Alpsoy, Erkan;
    • Şenel, Soner
    Publication type:
    Article
    12
    13
    14
    15

    Update on recommendations for eligibility of government subsidization of biologic disease‐modifying antirheumatic drugs for the treatment of axial spondyloarthritis in Singapore.

    Published in:
    International Journal of Rheumatic Diseases, 2020, v. 23, n. 2, p. 165, doi. 10.1111/1756-185X.13744
    By:
    • Phang, Kee Fong;
    • Lahiri, Manjari;
    • Fong, Warren Weng Seng;
    • Leong, Keng Hong;
    • Leung, Ying Ying;
    • Lim, Anita Yee Nah;
    • Lui, Nai Lee;
    • Manghani, Mona;
    • Tan, Teck Choon;
    • Santosa, Amelia;
    • Sriranganathan, Melonie Kannamma;
    • Suresh, Ernest;
    • Teng, Gim Gee;
    • Cheung, Peter P.
    Publication type:
    Article
    16
    17
    18

    Peripheral neuropathies in rheumatic diseases: More diverse and frequent than expected. A cross‐sectional study.

    Published in:
    International Journal of Rheumatic Diseases, 2020, v. 23, n. 2, p. 226, doi. 10.1111/1756-185X.13755
    By:
    • López‐López, Carlos Omar;
    • Montes Castillo, Maria de la Luz;
    • Soto‐Fajardo, Rosa Carina;
    • Sandoval‐García, León Felipe;
    • Loyola‐Sánchez, Adalberto;
    • Burgos‐Vargas, Rubén;
    • Peláez‐Ballestas, Ingris;
    • Álvarez Hernández, Everardo;
    • Vázquez‐Mellado, Janitzia
    Publication type:
    Article
    19

    Singapore chapter of rheumatologists' updated consensus statement on the eligibility for government subsidization of biologic and targeted therapy for the treatment of psoriatic arthritis.

    Published in:
    International Journal of Rheumatic Diseases, 2020, v. 23, n. 2, p. 153, doi. 10.1111/1756-185X.13754
    By:
    • Chua, Cheryl K. T.;
    • Teng, Gim Gee;
    • Cheung, Peter P.;
    • Fong, Warren Weng Seng;
    • Leong, Keng Hong;
    • Leung, Ying Ying;
    • Lim, Anita Y. N.;
    • Lui, Nai Lee;
    • Manghani, Mona;
    • Santosa, Amelia;
    • Sriranganathan, Melonie Kannamma;
    • Suresh, Ernest;
    • Tan, Teck Choon;
    • Lahiri, Manjari
    Publication type:
    Article
    20

    Issue Information.

    Published in:
    International Journal of Rheumatic Diseases, 2020, v. 23, n. 2, p. 131, doi. 10.1111/1756-185X.13621
    Publication type:
    Article
    21